Moolec Science (NASDAQ:MLEC) Upgraded by Wall Street Zen to “Hold” Rating

Wall Street Zen upgraded shares of Moolec Science (NASDAQ:MLEC) from a sell rating to a hold rating in a research note issued to investors on Saturday.

Moolec Science Trading Up 5.3%

NASDAQ:MLEC opened at $8.93 on Friday. The firm has a 50-day moving average price of $8.42 and a two-hundred day moving average price of $7.69. Moolec Science has a twelve month low of $3.08 and a twelve month high of $142.05. The company has a market capitalization of $6.52 million, a P/E ratio of -0.27 and a beta of 0.38.

Moolec Science (NASDAQ:MLEC) last posted its earnings results on Thursday, May 14th. The company reported $47.49 earnings per share for the quarter. The business had revenue of $2.62 million for the quarter.

Hedge Funds Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new stake in shares of Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent quarter. Institutional investors and hedge funds own 0.07% of the company’s stock.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.